Mustgrow Biologics Corp
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home … Read more
Mustgrow Biologics Corp (MGROF) - Total Liabilities
Latest total liabilities as of September 2025: $3.15 Million USD
Based on the latest financial reports, Mustgrow Biologics Corp (MGROF) has total liabilities worth $3.15 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Mustgrow Biologics Corp - Total Liabilities Trend (2016–2024)
This chart illustrates how Mustgrow Biologics Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Mustgrow Biologics Corp Competitors by Total Liabilities
The table below lists competitors of Mustgrow Biologics Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Valbiotis SAS
PA:ALVAL
|
France | €8.14 Million |
|
Ledlink Optics
TWO:5230
|
Taiwan | NT$1.02 Billion |
|
Malaysia Steel Works KL Bhd
KLSE:5098
|
Malaysia | RM1.50 Billion |
|
UNITEKNO Co.Ltd
KQ:241690
|
Korea | ₩104.81 Billion |
|
INFOvine co. Ltd
KQ:115310
|
Korea | ₩9.67 Billion |
|
Louisa Professional Coffee Ltd
TWO:2758
|
Taiwan | NT$2.87 Billion |
|
Chiho Environmental Group Limited
STU:T4N
|
Germany | €4.13 Billion |
|
B7X
F:B7X
|
Germany | €12.92 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Mustgrow Biologics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Mustgrow Biologics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Mustgrow Biologics Corp (2016–2024)
The table below shows the annual total liabilities of Mustgrow Biologics Corp from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $3.25 Million | +139.86% |
| 2023-12-31 | $1.35 Million | -28.58% |
| 2022-12-31 | $1.90 Million | +52.19% |
| 2021-12-31 | $1.25 Million | +18.94% |
| 2020-12-31 | $1.05 Million | -1.36% |
| 2019-12-31 | $1.06 Million | +4.08% |
| 2018-12-31 | $1.02 Million | +1605.01% |
| 2017-12-31 | $59.81K | +98.70% |
| 2016-12-31 | $30.10K | -- |